Jasper Therapeutics Stock Alpha and Beta Analysis
| JSPRW Stock | USD 0.09 0.01 8.70% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Jasper Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Jasper Therapeutics over a specified time horizon. Remember, high Jasper Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Jasper Therapeutics' market risk premium analysis include:
Beta 3.4 | Alpha (0.38) | Risk 8.57 | Sharpe Ratio 0.0606 | Expected Return 0.52 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Jasper Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Jasper Therapeutics market risk premium is the additional return an investor will receive from holding Jasper Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Jasper Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Jasper Therapeutics' performance over market.| α | -0.38 | β | 3.40 |
Jasper Therapeutics Fundamentals Vs Peers
Comparing Jasper Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Jasper Therapeutics' direct or indirect competition across all of the common fundamentals between Jasper Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Jasper Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Jasper Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Jasper Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Jasper Therapeutics to competition |
| Fundamentals | Jasper Therapeutics | Peer Average |
| Return On Equity | -1.01 | -0.31 |
| Return On Asset | -0.56 | -0.14 |
| Number Of Shares Shorted | 13.85 K | 4.71 M |
| EBITDA | (71.39 M) | 3.9 B |
| Net Income | (71.27 M) | 570.98 M |
| Cash And Equivalents | 16.76 M | 2.7 B |
| Cash Per Share | 1.65 X | 5.01 X |
Jasper Therapeutics Opportunities
Jasper Therapeutics Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Amplitude Healthcare Holdings Llc of 200000 shares of Jasper Therapeutics subject to Rule 16b-3 | 03/19/2025 |
2 | Disposition of tradable shares by Mahal Jeetinder Singh of Jasper Therapeutics subject to Rule 16b-3 | 05/09/2025 |
3 | Trading Report - news.stocktradersdaily.com | 05/16/2025 |
4 | Jasper Therapeutics Will Have To Spend Its Cash Wisely - Yahoo Finance | 05/29/2025 |
5 | Trend Tracker for - news.stocktradersdaily.com | 06/06/2025 |
6 | Insider Trading | 06/16/2025 |
7 | Acquisition by Lucas Svetlana of 7500 shares of Jasper Therapeutics at 6.77 subject to Rule 16b-3 | 07/02/2025 |
8 | Jasper Therapeutics plunges on drug product lot issues - Investing.com | 07/08/2025 |
About Jasper Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Jasper or other stocks. Alpha measures the amount that position in Jasper Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Current Ratio | 5.91 | 7.19 | 4.98 | 8.77 | Net Debt To EBITDA | 0.91 | 1.29 | 0.98 | 0.93 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Jasper Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Jasper Therapeutics' short interest history, or implied volatility extrapolated from Jasper Therapeutics options trading.
Build Portfolio with Jasper Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.